Question · asked by 0 reviews

RISPERIDONE vs placebo: Leaving the study early

Population
patients with schizophrenia
Intervention
RISPERIDONE
Comparison
placebo
Outcome
Leaving the study early

It is very uncertain whether risperidone changes leaving the study early compared with placebo (very low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Risperidone vs placebo
Leaving the study early · patients with schizophrenia
It is very uncertain whether risperidone changes leaving the study early compared with placebo (very low certainty).
Risperidone versus placebo for schizophrenia (2010) · Cochrane Headline outcomes onlyearlier version CD006918.PUB2, superseded
RR 0.7 [0.57, 0.86]11 studies · 1363 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Risperidone versus placebo for schizophrenia
2016 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.